Literature DB >> 12738629

Immunoglobulin G subisotype responses of pneumonic and healthy, exposed foals and adult horses to Rhodococcus equi virulence-associated proteins.

Kathleen E Hooper-McGrevy1, Bruce N Wilkie, John F Prescott.   

Abstract

Rhodococcus equi causes severe pyogranulomatous pneumonia in foals and in immunocompromised humans. Replication of virulent isolates within macrophages correlates with the presence of a large plasmid which encodes a family of seven virulence-associated proteins (VapA and VapC to VapH), whose functions are unknown. Although cell-mediated immunity is thought to be crucial in eliminating R. equi infection, antibody partially protects foals. The antibody response to both VapA and VapC was similar in six adult horses and six naturally exposed but healthy foals, as well as in eight foals with R. equi pneumonia. The immunoglobulin G (IgG) subisotype response of pneumonic foals to Vap proteins was significantly IgGb biased and also had a trend toward higher IgGT association compared to the isotype association of antibody in adult horses and healthy exposed foals. This suggests that in horses, IgGb and IgGT are Th2 isotypes and IgGa is a Th1 isotype. Furthermore, it suggests that foals which develop R. equi pneumonia have a Th2-biased, ineffective immune response whereas foals which become immune develop a Th1-biased immune response. Pneumonic foals had significantly more antibody to VapD and VapE than did healthy exposed foals. This may indicate a difference in the expression of these two Vap proteins during persistent infection. Alternatively, in pneumonic foals the deviation of the immune response toward VapD and VapE may reflect a bias unfavorable to R. equi resistance. These data indicate possible age-related differences in the equine immune response affecting Th1-Th2 bias as well as antibody specificity bias, which together favor the susceptibility of foals to R. equi pneumonia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12738629      PMCID: PMC154967          DOI: 10.1128/cdli.10.3.345-351.2003

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  45 in total

Review 1.  Neonatal immunity: how well has it grown up?

Authors:  S Marshall-Clarke; D Reen; L Tasker; J Hassan
Journal:  Immunol Today       Date:  2000-01

2.  DNA sequence and comparison of virulence plasmids from Rhodococcus equi ATCC 33701 and 103.

Authors:  S Takai; S A Hines; T Sekizaki; V M Nicholson; D A Alperin; M Osaki; D Takamatsu; M Nakamura; K Suzuki; N Ogino; T Kakuda; H Dan; J F Prescott
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

3.  Identification of pulmonary T-lymphocyte and serum antibody isotype responses associated with protection against Rhodococcus equi.

Authors:  A Marianela Lopez; Melissa T Hines; Guy H Palmer; Debra C Alperin; Stephen A Hines
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

4.  Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4- or IL-13-mediated signaling.

Authors:  J M Brewer; M Conacher; C A Hunter; M Mohrs; F Brombacher; J Alexander
Journal:  J Immunol       Date:  1999-12-15       Impact factor: 5.422

5.  Ontogenetic development of T- and B-lymphocytes and non-lymphoid cells in the white pulp of the rat spleen.

Authors:  C D Dijkstra; E A Döpp
Journal:  Cell Tissue Res       Date:  1983       Impact factor: 5.249

6.  Increase of immunoglobulin T concentration in ponies as a response to experimental infection with the nematode Strongylus vulgaris.

Authors:  S Patton; R E Mock; J H Drudge; D Morgan
Journal:  Am J Vet Res       Date:  1978-01       Impact factor: 1.156

7.  Evaluation of equine immunoglobulin specific for Rhodococcus equi virulence-associated proteins A and C for use in protecting foals against Rhodococcus equi-induced pneumonia.

Authors:  K E Hooper-McGrevy; S Giguere; B N Wilkie; J F Prescott
Journal:  Am J Vet Res       Date:  2001-08       Impact factor: 1.156

8.  Human in vitro immune responses to Mycobacterium tuberculosis.

Authors:  M L Wilsher; C Hagan; R Prestidge; A U Wells; G Murison
Journal:  Tuber Lung Dis       Date:  1999

9.  Surface receptors on neutrophils and monocytes from immunodeficient and normal horses.

Authors:  K L Banks; T C McGuire
Journal:  Immunology       Date:  1975-03       Impact factor: 7.397

10.  The interaction of Corynebacterium equi and equine alveolar macrophages in vitro.

Authors:  M C Zink; J A Johnson; J F Prescot; P J Pascoe
Journal:  J Reprod Fertil Suppl       Date:  1982
View more
  11 in total

1.  VapA of Rhodococcus equi binds phosphatidic acid.

Authors:  Lindsay M Wright; Emily M Carpinone; Terry L Bennett; Mary K Hondalus; Vincent J Starai
Journal:  Mol Microbiol       Date:  2017-12-22       Impact factor: 3.501

2.  PNAG-specific equine IgG1 mediates significantly greater opsonization and killing of Prescottella equi (formerly Rhodococcus equi) than does IgG4/7.

Authors:  Joana N Rocha; Lawrence J Dangott; Waithaka Mwangi; Robert C Alaniz; Angela I Bordin; Colette Cywes-Bentley; Sara D Lawhon; Suresh D Pillai; Jocelyne M Bray; Gerald B Pier; Noah D Cohen
Journal:  Vaccine       Date:  2019-01-26       Impact factor: 3.641

3.  Experimental infection of neonatal foals with Rhodococcus equi triggers adult-like gamma interferon induction.

Authors:  Stephanie Jacks; Steeve Giguère; P Cynda Crawford; William L Castleman
Journal:  Clin Vaccine Immunol       Date:  2007-04-04

4.  Polymorphisms in equine immune response genes and their associations with infections.

Authors:  Petr Horín; Jirrí Smola; Ján Matiasovic; Mirko Vyskocil; Ludmila Lukeszová; Katarína Tomanová; Petr Králík; Vladimír Glasnák; Dana Schröffelová; Ales Knoll; Markéta Sedlinská; Leona Krenková; Petr Jahn
Journal:  Mamm Genome       Date:  2004-10       Impact factor: 2.957

5.  In vivo expression of and cell-mediated immune responses to the plasmid-encoded virulence-associated proteins of Rhodococcus equi in foals.

Authors:  Stephanie Jacks; Steeve Giguère; John F Prescott
Journal:  Clin Vaccine Immunol       Date:  2007-02-14

6.  Failure of a VapA/CpG oligodeoxynucleotide vaccine to protect foals against experimental Rhocococcus equi pneumonia despite induction of VapA-specific antibody and interferon-γ response.

Authors:  Katharina L Lohmann; A Marianela Lopez; Stephen T Manning; Fernando J Marques; Robert Brownlie; Andrew L Allen; Anna E Sangster; George Mutwiri; Volker Gerdts; Andrew Potter; Hugh G G Townsend
Journal:  Can J Vet Res       Date:  2013-07       Impact factor: 1.310

7.  The effect of CpG-ODN on antigen presenting cells of the foal.

Authors:  M Julia B F Flaminio; Alexandre S Borges; Daryl V Nydam; David W Horohov; Rolf Hecker; Mary Beth Matychak
Journal:  J Immune Based Ther Vaccines       Date:  2007-01-25

8.  Immunogenicity of an electron beam inactivated Rhodococcus equi vaccine in neonatal foals.

Authors:  Angela I Bordin; Suresh D Pillai; Courtney Brake; Kaytee B Bagley; Jessica R Bourquin; Michelle Coleman; Fabiano N Oliveira; Waithaka Mwangi; David N McMurray; Charles C Love; Maria Julia B Felippe; Noah D Cohen
Journal:  PLoS One       Date:  2014-08-25       Impact factor: 3.240

9.  Gastrointestinal helminths may affect host susceptibility to anthrax through seasonal immune trade-offs.

Authors:  Carrie A Cizauskas; Wendy C Turner; Bettina Wagner; Martina Küsters; Russell E Vance; Wayne M Getz
Journal:  BMC Ecol       Date:  2014-11-12       Impact factor: 2.964

10.  A Heterologous Multiepitope DNA Prime/Recombinant Protein Boost Immunisation Strategy for the Development of an Antiserum against Micrurus corallinus (Coral Snake) Venom.

Authors:  Henrique Roman Ramos; Inácio de Loiola M Junqueira-de-Azevedo; Juliana Branco Novo; Karen Castro; Clara Guerra Duarte; Ricardo A Machado-de-Ávila; Carlos Chavez-Olortegui; Paulo Lee Ho
Journal:  PLoS Negl Trop Dis       Date:  2016-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.